Skip to main content
Top
Published in: Current Cardiology Reports 9/2018

Open Access 01-09-2018 | Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients

Authors: S. W. E. Baalman, A. B. E. Quast, T. F. Brouwer, R. E. Knops

Published in: Current Cardiology Reports | Issue 9/2018

Login to get access

Abstract

Purpose of Review

Clear guidelines on when to select a subcutaneous ICD (S-ICD) over a transvenous ICD (TV-ICD) are lacking. This review will provide an overview of the most recent clinical data on S-ICD and TV-ICD therapy by pooling comparison studies in order to aid clinical decision making.

Recent Findings

Pooling of observational-matched studies demonstrated an incidence rate ratio (IRR) for device-related complication of 0.90 (95% CI 0.58–1.42) and IRR for lead-related complications of 0.15 (95% CI 0.06–0.39) in favor of S-ICD. The IRR for device infections was 2.00 (95% CI 0.95–4.22) in favor of TV-ICD. Both appropriate shocks (IRR 0.67 (95% CI 0.42–1.06)) and inappropriate shocks (IRR 1.17 (95% CI 0.77–1.79)) did not differ significantly between both groups.

Summary

With randomized data underway, the observational data demonstrate that the S-ICD is associated with reduced lead complications, but this has not yet resulted in a significant reduction in total number of complications compared to TV-ICDs. New technologies are expected to make the S-ICD a more attractive alternative.
Literature
1.
go back to reference Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA III, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012;126(14):1784–800.CrossRefPubMed Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA III, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012;126(14):1784–800.CrossRefPubMed
2.
go back to reference Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303(6):322–4. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303(6):322–4.
3.
go back to reference Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.CrossRefPubMed Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.CrossRefPubMed
4.
go back to reference Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med. 2010;363(1):36–44. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med. 2010;363(1):36–44.
5.
go back to reference Quast ABE, van Dijk VF, Yap SC, Maass AH, Boersma LVA, Theuns DA, et al. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity. Journal of cardiovascular electrophysiology. 2018. Quast ABE, van Dijk VF, Yap SC, Maass AH, Boersma LVA, Theuns DA, et al. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity. Journal of cardiovascular electrophysiology. 2018.
6.
go back to reference Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–15. Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–15.
7.
go back to reference Basu-Ray I, Liu J, Jia X, Gold M, Ellenbogen K, DiNicolantonio J, et al. Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies. JACC Clin Electrophysiol.. 2017;3(13):1475–83. Basu-Ray I, Liu J, Jia X, Gold M, Ellenbogen K, DiNicolantonio J, et al. Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies. JACC Clin Electrophysiol.. 2017;3(13):1475–83.
8.
go back to reference Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, et al. Rationale and design of the PRAETORIAN trial: a prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J. 2012;163(5):753–60.e2.CrossRefPubMed Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, et al. Rationale and design of the PRAETORIAN trial: a prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J. 2012;163(5):753–60.e2.CrossRefPubMed
9.
go back to reference Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793–867.CrossRefPubMed Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793–867.CrossRefPubMed
10.
go back to reference Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. https://doi.org/10.1016/j.hrthm.2017.10.036. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. https://​doi.​org/​10.​1016/​j.​hrthm.​2017.​10.​036.
11.
go back to reference Brouwer TF, Knops RE, Kutyifa V, Barr C, Mondesert B, Boersma LVA, et al. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. [published online ahead of print May 15, 2018]. Europace. https://doi.org/10.1093/europace/euy083. Brouwer TF, Knops RE, Kutyifa V, Barr C, Mondesert B, Boersma LVA, et al. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. [published online ahead of print May 15, 2018]. Europace. https://​doi.​org/​10.​1093/​europace/​euy083.
12.
go back to reference Mithani AA, Kath H, Hunter K, Andriulli J, Ortman M, Field J, et al. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement. Europace. 2018;20(2):308–14. Mithani AA, Kath H, Hunter K, Andriulli J, Ortman M, Field J, et al. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement. Europace. 2018;20(2):308–14.
13.
go back to reference Lenarczyk R, Boveda S, Haugaa KH, Potpara TS, Syska P, Jedrzejczyk-Patej E, et al. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI). Europace. 2018; Lenarczyk R, Boveda S, Haugaa KH, Potpara TS, Syska P, Jedrzejczyk-Patej E, et al. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI). Europace. 2018;
14.
go back to reference Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, et al. Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1(8):900–11. Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, et al. Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1(8):900–11.
15.
go back to reference Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LRA, Schalij MJ, et al. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol. 2016;68(19):2047–55. Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LRA, Schalij MJ, et al. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol. 2016;68(19):2047–55.
16.
go back to reference Honarbakhsh S, Providencia R, Srinivasan N, Ahsan S, Lowe M, Rowland E, et al. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. Int J Cardiol. 2017;228:280–5. Honarbakhsh S, Providencia R, Srinivasan N, Ahsan S, Lowe M, Rowland E, et al. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. Int J Cardiol. 2017;228:280–5.
17.
go back to reference Kobe J, Reinke F, Meyer C, Shin DI, Martens E, Kaab S, et al. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm. 2013;10(1):29–36.CrossRefPubMed Kobe J, Reinke F, Meyer C, Shin DI, Martens E, Kaab S, et al. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm. 2013;10(1):29–36.CrossRefPubMed
18.
go back to reference Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, et al. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013;6(4):488–97. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, et al. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013;6(4):488–97.
19.
go back to reference Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474–80. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474–80.
20.
go back to reference Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012;25(3):245–52.CrossRefPubMed Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012;25(3):245–52.CrossRefPubMed
21.
go back to reference Tarakji KG, Ellis CR, Defaye P, Kennergren C. Cardiac implantable electronic device infection in patients at risk.Arrhythm Electrophysiol Rev. 2016;5(1):65–71. Tarakji KG, Ellis CR, Defaye P, Kennergren C. Cardiac implantable electronic device infection in patients at risk.Arrhythm Electrophysiol Rev. 2016;5(1):65–71.
22.
go back to reference Gold MR, Aasbo JD, El-Chami MF, Niebauer M, Herre J, Prutkin JM, et al. Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results. Heart Rhythm. 2017;14(10):1456–63. Gold MR, Aasbo JD, El-Chami MF, Niebauer M, Herre J, Prutkin JM, et al. Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results. Heart Rhythm. 2017;14(10):1456–63.
23.
go back to reference Olde Nordkamp LR, Postema PG, Knops RE, van Dijk N, Limpens J, Wilde AA, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13(2):443–54.CrossRefPubMed Olde Nordkamp LR, Postema PG, Knops RE, van Dijk N, Limpens J, Wilde AA, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13(2):443–54.CrossRefPubMed
24.
go back to reference • Theuns D, Brouwer TF, Jones P, Allavatam V, Donnelley S, Auricchio A, et al. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. [published online ahead of print June 8, 2018]. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2018.05.011. This article demonstrates that enabling the SMARTPASS filter in S-ICDs results in a significant reductions of inappropriate shocks. This article demonstrates that enabling the SMARTPASS filter in S-ICDs results in a significant reductions of inappropriate shocks. • Theuns D, Brouwer TF, Jones P, Allavatam V, Donnelley S, Auricchio A, et al. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. [published online ahead of print June 8, 2018]. Heart Rhythm. https://​doi.​org/​10.​1016/​j.​hrthm.​2018.​05.​011. This article demonstrates that enabling the SMARTPASS filter in S-ICDs results in a significant reductions of inappropriate shocks. This article demonstrates that enabling the SMARTPASS filter in S-ICDs results in a significant reductions of inappropriate shocks.
25.
go back to reference van der Heijden AC, Borleffs CJW, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, et al. The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm. 2015;12(6):1169–76. van der Heijden AC, Borleffs CJW, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, et al. The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm. 2015;12(6):1169–76.
26.
go back to reference Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–329. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–329.
27.
go back to reference Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.CrossRefPubMed Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.CrossRefPubMed
28.
go back to reference Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–83. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–83.
29.
go back to reference •• Tjong FVY, Brouwer TF, Kooiman KM, Smeding L, Koop B, Soltis B, et al. Communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable defibrillator. J Am Coll Cardiol. 2016;67(15):1865–6. This article demonstrates successful S-ICD to LCP communication and ATP delivery by the LCP. This article demonstrates successful S-ICD to LCP communication and ATP delivery by the LCP. •• Tjong FVY, Brouwer TF, Kooiman KM, Smeding L, Koop B, Soltis B, et al. Communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable defibrillator. J Am Coll Cardiol. 2016;67(15):1865–6. This article demonstrates successful S-ICD to LCP communication and ATP delivery by the LCP. This article demonstrates successful S-ICD to LCP communication and ATP delivery by the LCP.
30.
go back to reference Essandoh MK, Mark GE, Aasbo JD, Joyner CA, Sharma S, Decena BF, Bolin ED, Weiss R, Burke MC, McClernon TR, Daoud EG, Gold MR Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: perspectives from the clinical experience of a US panel of physicians. [published online ahead of print May 13, 2018]. Pacing Clin Electrophysiol. Essandoh MK, Mark GE, Aasbo JD, Joyner CA, Sharma S, Decena BF, Bolin ED, Weiss R, Burke MC, McClernon TR, Daoud EG, Gold MR Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: perspectives from the clinical experience of a US panel of physicians. [published online ahead of print May 13, 2018]. Pacing Clin Electrophysiol.
31.
go back to reference Miller MA, Bhatt HV, Weiner M, Brouwer TF, Mittnacht AJ, Shariat A, et al. Implantation of the subcutaneous implantable cardioverter-defibrillator with truncal plane blocks. Heart Rhythm. 2018;15:1108–11. Miller MA, Bhatt HV, Weiner M, Brouwer TF, Mittnacht AJ, Shariat A, et al. Implantation of the subcutaneous implantable cardioverter-defibrillator with truncal plane blocks. Heart Rhythm. 2018;15:1108–11.
32.
go back to reference Droghetti A, Basso Ricci E, Scimia P, Harizai F, Marini M. Ultrasound-guided serratus anterior plane block combined with the two-incision technique for subcutaneous ICD implantation. Pacing Clin Electrophysiol. 2018;41(5):517–23.CrossRefPubMed Droghetti A, Basso Ricci E, Scimia P, Harizai F, Marini M. Ultrasound-guided serratus anterior plane block combined with the two-incision technique for subcutaneous ICD implantation. Pacing Clin Electrophysiol. 2018;41(5):517–23.CrossRefPubMed
33.
go back to reference Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm. 2016;32(1):1–28. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm. 2016;32(1):1–28.
34.
go back to reference • Heist EK, Belalcazar A, Stahl W, Brouwer TF, Knops RE. Determinants of subcutaneous implantable cardioverter-defibrillator efficacy: a computer modeling study. JACC Clin Electrophysiol. 2017;3(4):405–14. This article demonstrates the impact of underlying fat tissue and position of the S-ICD generator on defibrillation threshold. This article demonstrates the impact of underlying fat tissue and position of the S-ICD generator on defibrillation threshold. • Heist EK, Belalcazar A, Stahl W, Brouwer TF, Knops RE. Determinants of subcutaneous implantable cardioverter-defibrillator efficacy: a computer modeling study. JACC Clin Electrophysiol. 2017;3(4):405–14. This article demonstrates the impact of underlying fat tissue and position of the S-ICD generator on defibrillation threshold. This article demonstrates the impact of underlying fat tissue and position of the S-ICD generator on defibrillation threshold.
Metadata
Title
An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients
Authors
S. W. E. Baalman
A. B. E. Quast
T. F. Brouwer
R. E. Knops
Publication date
01-09-2018
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 9/2018
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-018-1021-8

Other articles of this Issue 9/2018

Current Cardiology Reports 9/2018 Go to the issue

Peripheral Vascular Disease (CJ Cooper and R Gupta, Section Editors)

Preventing Major Amputations in Patients with Critical Limb Ischemia

Heart Failure (H Eisen, Section Editor)

Complications of Cardiac Transplantation

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia